Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020-2021

Emerg Infect Dis. 2022 Oct;28(10):2027-2034. doi: 10.3201/eid2810.220847.

Abstract

Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions.

Keywords: Senegal; acute flaccid paralysis; environmental surveillance; polio; vaccine-derived poliovirus serotype 2; viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Environmental Monitoring
  • Humans
  • Phylogeny
  • Poliomyelitis* / epidemiology
  • Poliomyelitis* / prevention & control
  • Poliovirus Vaccine, Oral / adverse effects
  • Poliovirus* / genetics
  • Senegal / epidemiology
  • Serogroup
  • Sewage

Substances

  • Poliovirus Vaccine, Oral
  • Sewage